<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3027">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01445652</url>
  </required_header>
  <id_info>
    <org_study_id>P-370-C-091 / CB11-500</org_study_id>
    <nct_id>NCT01445652</nct_id>
  </id_info>
  <brief_title>A Lifestyle Investigation With Spectacles and Daily Disposable Contact Lenses in Young Patients</brief_title>
  <official_title>A Lifestyle Investigation With Spectacles and Daily Disposable Contact Lenses in Young Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CIBA VISION</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Manchester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to evaluate the relative benefits of daily disposable contact
      lenses versus spectacles in young adults.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Subjective Happiness With Correction Type</measure>
    <time_frame>Month 6</time_frame>
    <safety_issue>No</safety_issue>
    <description>Participant responded to an SMS message: &quot;Please rate your happiness (H) and vision (V) with your [contact lenses/spectacles]: 1=very poor; 2=poor; 3=neither; 4=good; and 5=very good. eg H2V4. Please send N if in you are not wearing [contact lenses/spectacles].&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Vision With Correction Type</measure>
    <time_frame>Month 6</time_frame>
    <safety_issue>No</safety_issue>
    <description>Participant responded to an SMS message: &quot;Please rate your happiness (H) and vision (V) with your [contact lenses/spectacles]: 1=very poor; 2=poor; 3=neither; 4=good; and 5=very good. eg H2V4. Please send N if in you are not wearing [contact lenses/spectacles].&quot;</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">113</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>nelfilcon A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nelfilcon A contact lenses worn in both eyes on a daily disposable basis a minimum of five days per week, eight hours per day, for six months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spectacles</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spectacles per current prescription worn a minimum of five days per week, eight hours per day, for six months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nelfilcon A contact lens</intervention_name>
    <description>Commercially marketed, single vision, soft contact lens for daily disposable wear</description>
    <arm_group_label>nelfilcon A</arm_group_label>
    <other_name>DAILIES AQUACOMFORT PLUS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spectacles</intervention_name>
    <description>Spectacles per current prescription</description>
    <arm_group_label>Spectacles</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Understands rights as a research subject and willing and able to sign a Statement of
             Informed Consent, or if under 18, parent or guardian understands rights and is
             willing and able to sign a Statement of Informed Consent.

          -  Willing and able to follow the protocol.

          -  Currently wearing spectacles full-time (at least five days per week, eight hours per
             day).

          -  Has never worn contact lenses (more than one day) before.

          -  Agrees to not participate in other clinical research for the duration of this study.

          -  Can attain at least 6/9 in each eye with the study optical correction.

          -  Can be fitted with study lenses in the available power range (contact lens group) or
             can select a satisfactory spectacle lens frame and lenses (spectacle group).

          -  Willing and able to wear the study lenses or spectacles for a minimum of five days
             per week, eight hours per day.

          -  Owns or has regular access to a mobile phone and is familiar with SMS text messaging.

          -  Has an up-to-date and functional pair of spectacles at time of enrollment.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Has an ocular or systemic disorder that would normally contraindicate contact lens
             wear.

          -  Is using any topical medication such as eye drops or ointment.

          -  Has had corneal refractive surgery.

          -  Has had cataract surgery.

          -  Has diabetes.

          -  Has taken part in other clinical research within two weeks of starting the study.

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip Morgan, PhD MCOptom FAAO FBCLA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manchester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eurolens Research</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9PT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 11, 2013</lastchanged_date>
  <firstreceived_date>September 30, 2011</firstreceived_date>
  <firstreceived_results_date>June 28, 2013</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were enrolled from one study center in the United Kingdom.</recruitment_details>
      <pre_assignment_details>Of the 113 participants enrolled, 3 were exited as screen failures prior to randomization. This reporting group includes all enrolled and randomized participants (110).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Nelfilcon A</title>
          <description>Nelfilcon A contact lenses worn in both eyes on a daily disposable basis a minimum of five days per week, eight hours per day, for six months</description>
        </group>
        <group group_id="P2">
          <title>Spectacles</title>
          <description>Spectacles per current prescription worn a minimum of five days per week, eight hours per day, for six months</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Not comfortable in lenses</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Failed to attend scheduled visit</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Failed teach session</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This reporting group includes all enrolled and randomized participants.</population>
      <group_list>
        <group group_id="B1">
          <title>Nelfilcon A</title>
          <description>Nelfilcon A contact lenses worn in both eyes on a daily disposable basis a minimum of five days per week, eight hours per day, for six months</description>
        </group>
        <group group_id="B2">
          <title>Spectacles</title>
          <description>Spectacles per current prescription worn a minimum of five days per week, eight hours per day, for six months</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="57"/>
                <measurement group_id="B2" value="53"/>
                <measurement group_id="B3" value="110"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="16.2" spread="1.8"/>
                <measurement group_id="B2" value="16.3" spread="2.0"/>
                <measurement group_id="B3" value="16.2" spread="1.9"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="32"/>
                <measurement group_id="B2" value="31"/>
                <measurement group_id="B3" value="63"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="25"/>
                <measurement group_id="B2" value="22"/>
                <measurement group_id="B3" value="47"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United Kingdom</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="57"/>
                <measurement group_id="B2" value="53"/>
                <measurement group_id="B3" value="110"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Subjective Happiness With Correction Type</title>
        <description>Participant responded to an SMS message: &quot;Please rate your happiness (H) and vision (V) with your [contact lenses/spectacles]: 1=very poor; 2=poor; 3=neither; 4=good; and 5=very good. eg H2V4. Please send N if in you are not wearing [contact lenses/spectacles].&quot;</description>
        <time_frame>Month 6</time_frame>
        <safety_issue>No</safety_issue>
        <population>This reporting group includes all participants who sent in an SMS response.</population>
        <group_list>
          <group group_id="O1">
            <title>Nelfilcon A</title>
            <description>Nelfilcon A contact lenses worn in both eyes on a daily disposable basis a minimum of five days per week, eight hours per day, for six months</description>
          </group>
          <group group_id="O2">
            <title>Spectacles</title>
            <description>Spectacles per current prescription worn a minimum of five days per week, eight hours per day, for six months</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="14"/>
                  <measurement group_id="O2" value="21"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Subjective Happiness With Correction Type</title>
            <description>Participant responded to an SMS message: &quot;Please rate your happiness (H) and vision (V) with your [contact lenses/spectacles]: 1=very poor; 2=poor; 3=neither; 4=good; and 5=very good. eg H2V4. Please send N if in you are not wearing [contact lenses/spectacles].&quot;</description>
            <units>Units on a Scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4.92" spread="0.3"/>
                  <measurement group_id="O2" value="4.50" spread="0.9"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Vision With Correction Type</title>
        <description>Participant responded to an SMS message: &quot;Please rate your happiness (H) and vision (V) with your [contact lenses/spectacles]: 1=very poor; 2=poor; 3=neither; 4=good; and 5=very good. eg H2V4. Please send N if in you are not wearing [contact lenses/spectacles].&quot;</description>
        <time_frame>Month 6</time_frame>
        <safety_issue>No</safety_issue>
        <population>This reporting group includes all participants who sent in an SMS response.</population>
        <group_list>
          <group group_id="O1">
            <title>Nelfilcon A</title>
            <description>Nelfilcon A contact lenses worn in both eyes on a daily disposable basis a minimum of five days per week, eight hours per day, for six months</description>
          </group>
          <group group_id="O2">
            <title>Spectacles</title>
            <description>Spectacles per current prescription worn a minimum of five days per week, eight hours per day, for six months</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="14"/>
                  <measurement group_id="O2" value="21"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Subjective Vision With Correction Type</title>
            <description>Participant responded to an SMS message: &quot;Please rate your happiness (H) and vision (V) with your [contact lenses/spectacles]: 1=very poor; 2=poor; 3=neither; 4=good; and 5=very good. eg H2V4. Please send N if in you are not wearing [contact lenses/spectacles].&quot;</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4.5" spread="0.7"/>
                  <measurement group_id="O2" value="4.5" spread="0.8"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected for the duration of the study (9 months). An adverse event was defined as any unfavourable or unintended sign or symptom associated with the use of a contact lens, but not necessarily caused by the contact lens.</time_frame>
      <desc>This reporting group includes all enrolled and randomized participants.</desc>
      <group_list>
        <group group_id="E1">
          <title>Nelfilcon A</title>
          <description>Nelfilcon A contact lenses worn in both eyes on a daily disposable basis a minimum of five days per week, eight hours per day, for six months</description>
        </group>
        <group group_id="E2">
          <title>Spectacles</title>
          <description>Spectacles per current prescription worn a minimum of five days per week, eight hours per day, for six months</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Corneal inflammatory event</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor reserves the right of prior review of any publication or presentation of information related to the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jami Kern, PhD</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>1-888-451-3937</phone>
      <email>alcon.medinfo@alcon.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
